At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BGLC BioNexus Gene Lab Corp.
Trading 04-02 11:18:23 EDT
0.2700
+0.0100
+3.85%
| High0.2700 | Low0.2501 | Vol35.98K |
| Open0.2595 | D1 Closing0.2600 | Amplitude7.65% |
| Mkt Cap4.85M | Tradable Cap3.35M | Total Shares17.97M |
| T/O9.10K | T/O Rate0.29% | Tradable Shares12.40M |
| P/B-- | ROE-- | EPS0.00 |
| 52wk High-- | 52wk Low-- | P/E-- |
| Dividend-- | Div.Yield-- | ROA-- |
Loading ...
BioNexus Gene Partners With ML Tech for Treasury Strategy
MT Newswires Live · 03-07
Bionexus Gene Lab enters partnership with ML Tech
TIPRANKS · 03-07
BioNexus Gene Lab Corp and ML Tech Partner to Enhance Ethereum-focused Treasury Strategy
GlobeNewswire · 03-07
BioNexus Gene Lab Becomes First Nasdaq-Listed Company to Embrace Ethereum as Treasury Asset
BE[IN]CRYPTO · 03-06
BioNexus Gene Lab Becomes First Nasdaq-Listed Company to Embrace Ethereum as Treasury Asset
BioNexus Stock Pops As It Embraces Ethereum-Focused Treasury Strategy, Says It Is First On Nasdaq To Do So
Benzinga · 03-06
BioNexus Stock Pops As It Embraces Ethereum-Focused Treasury Strategy, Says It Is First On Nasdaq To Do So
BioNexus Gene Reports Approval of Ethereum Treasury Strategy
MT Newswires Live · 03-05
BRIEF-Bionexus Gene Lab Corp Announces Board Approval Of Ethereum Treasury Strategy And Release Of Strategic Whitepaper
Reuters · 03-05
Bionexus Gene Lab announces board approval of Ethereum treasury strategy
TIPRANKS · 03-05
BioNexus Gene Lab Corp. Announces Board Approval of Ethereum Treasury Strategy and Release of Strategic Whitepaper
THOMSON REUTERS · 03-05
BioNexus Gene Lab Corp. Announces Board Approval of Ethereum Treasury Strategy and Release of Strategic Whitepaper
GlobeNewswire · 03-05
Sector Update: Health Care Stocks Softer Late Afternoon
MT Newswires Live · 01-02
BioNexus Gene Lab Given Until May 1 to Regain Nasdaq Compliance; Shares Rise
MT Newswires Live · 01-02
BioNexus Gene Lab Leads Our Top 3 US Penny Stocks
Simply Wall St. · 2024-12-06
BioNexus Gene Lab Leads Our Top 3 US Penny Stocks
BioNexus Gene Lab Faces Delisting and Leadership Changes
TIPRANKS · 2024-11-08
BRIEF-Bionexus Gene Lab Corp -On Nov 5, Got Notification From Nasdaq, Co To Be Delisted From Nasdaq Due To Its Failure To Comply With Listing Rule
Reuters · 2024-11-08
BioNexus Gene Lab Corp -on Nov 5, Got Notification From Nasdaq, Co to Be Delisted From Nasdaq Due to Its Failure to Comply With Listing Rule
THOMSON REUTERS · 2024-11-08
BioNexus Gene Lab Corp -on Nov 8, Co Submitted Formal Request for a Hearing Before Nasdaq Hearings Panel to Appeal Delisting Determination
THOMSON REUTERS · 2024-11-08
BRIEF-Bionexus Gene Lab Corp Announces Three-Year Agreement To Develop Biogas Projects In Malaysia
Reuters · 2024-09-25
BioNexus Gene Lab Unit, Protech Builders to Develop Biogas Plants in Malaysia; Shares Rise
MT Newswires Live · 2024-09-25
Bionexus unit, Protech Builders sign strategic teaming agreement
TIPRANKS · 2024-09-25
Introduction
Company Name.
BioNexus Gene Lab Corp.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments. The company, through its subsidiary, BioNexus Gene Lab Sdn. Bhd, is also involved in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.
Issue price:
--
Invest in Global Markets with Tiger Brokers!Open App